Holdings of Tri Locum Partners LP
15 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 86 % of the equity sleeve
Sector breakdown
- Health care 68.1 %
- Unattributed 31.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 83.4 %
- DK 8.6 %
- IL 4.6 %
- NL 3.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 12 | 563.3M $ | 83.38 % |
| 2 | DK | 1 | 58.4M $ | 8.64 % |
| 3 | IL | 1 | 30.8M $ | 4.55 % |
| 4 | NL | 1 | 23.1M $ | 3.42 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 414,503 | 101.3M $ | |
| 2 | Intuitive Surgical Inc | 153,250 | 70.6M $ | |
| 3 | Thermo Fisher Scientific Inc | 132,413 | 65.1M $ | |
| 4 | Ascendis Pharma A/S | 255,332 | 58.4M $ | |
| 5 | Vertex Pharmaceuticals Inc | 129,314 | 57.7M $ | |
| 6 | Eli Lilly & Co | 61,795 | 56.8M $ | |
| 7 | Madrigal Pharmaceuticals Inc | 103,288 | 54.1M $ | |
| 8 | Dexcom Inc | 698,158 | 43.8M $ | |
| 9 | United Therapeutics Corp | 70,370 | 41.7M $ | |
| 10 | Nuvalent Inc | 308,506 | 31.6M $ | |
| 11 | Teva Pharmaceutical Industries Ltd | 1,021,008 | 30.8M $ | |
| 12 | Argenx SE | 31,635 | 23.1M $ | |
| 13 | Tarsus Pharmaceuticals Inc | 252,588 | 17.7M $ | |
| 14 | Dianthus Therapeutics Inc | 145,543 | 12.2M $ | |
| 15 | Axsome Therapeutics Inc | 62,116 | 10.5M $ |